Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. ... Aspirin for prevention of cardiovascular disease. Prev Chronic Dis. 2017;14:E77. [PMID: 28880838] doi:10.5888/pcd14.170171.
The main finding of this study does not, of course, diminish the importance of adiposity as a major modifiable determinant of cardiovascular disease," the authors wrote. ... Rather, because excess adiposity is a major determinant of the intermediate risk
3. Individuals with diabetes aged 40 to 75 years old with LDL-cholesterol levels between 70 and 189 mg/dL and without evidence of atherosclerotic cardiovascular disease. ... The risk score does not take into account family history of premature
To determine whether all-cause and cardiovascular disease mortality declined between 1997 and 2006, researchers from the Centers of Disease Control and Prevention compared 3-year death rates of four consecutive ... Results appeared in the June issue of
Statins have proven their potential to reduce end-point outcomes, such as death from cardiovascular disease, Dr. ... Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement.
The initial concern was raised by the FDA in their review of a study of 700 patients with known cardiovascular disease randomized to Chantix or placebo. ... The new study is a meta-analysis of studies looking at patients on Chantix without cardiovascular
The study took place in Spain and randomized over 7,000 people who did not have cardiovascular disease at the start of the study but had risk factors for cardiovascular disease, ... Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Aspirin has been shown to reduce the risk of cardiovascular disease, including heart attack and stroke. ... Further study is ongoing to research the issue of primary prevention of cardiovascular disease with aspirin in diabetic patients.
Management of dyslipidemia for cardiovascular disease risk reduction: Synopsis of the 2014 U.S. ... Cost-effectiveness of 10-year risk thresholds for initiation of statin therapy for primary prevention of cardiovascular disease.
Readers of this blog know that I am a big proponent of cholesterol-lowering medications like Lipitor for patients at moderate to high risk of cardiovascular disease. ... They can argue that cardiovascular disease is the number one killer in the US, and